Dr. Mark Levis, MD

Claim this profile

Johns Hopkins Cancer Center

Studies Acute Myeloid Leukemia
Studies Myeloid Neoplasms
3 reported clinical trials
6 drugs studied

Area of expertise

1

Acute Myeloid Leukemia

Mark Levis, MD has run 2 trials for Acute Myeloid Leukemia. Some of their research focus areas include:

FLT3 positive
NPM1 positive
KMT2A (MLL)-fusion positive
2

Myeloid Neoplasms

Mark Levis, MD has run 1 trial for Myeloid Neoplasms. Some of their research focus areas include:

HLA-A
HLA-B
HLA-DR

Affiliated Hospitals

Image of trial facility.

Johns Hopkins Cancer Center

Image of trial facility.

Johns Hopkins

Clinical Trials Mark Levis, MD is currently running

More about Mark Levis, MD

Clinical Trial Related

3 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 1 Active Clinical Trial

Treatments Mark Levis, MD has experience with

  • Ivosidenib
  • DSP-5336
  • Cytarabine
  • Daunorubicin
  • Gilteritinib
  • Midostaurin

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Mark Levis, MD specialize in?

Is Mark Levis, MD currently recruiting for clinical trials?

Are there any treatments that Mark Levis, MD has studied deeply?

What is the best way to schedule an appointment with Mark Levis, MD?

What is the office address of Mark Levis, MD?

Is there any support for travel costs?